Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...

The U.S. Supreme Court on Monday requested the opinion of the Solicitor General in a legal dispute involving Bayer’s ( ...

Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

For years, Bayer AG was one of Germany’s worst-performing stocks. Now, it’s turning out to be among the biggest gainers. The pharma and chemical conglomerate soared some 40% in 2025, ranking ...

A history of BayerBayer has been around for more than 150 years, and has continued to evolve throughout its long history Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in ...

Bayer also recently submitted gadoquatrane for approval in Japan. The company plans to submit further regulatory applications to health authorities worldwide in the coming months, it said.

Bayer wanted Missouri to protect it from Roundup lawsuits. The bill failed — but it may return St. Louis Public Radio | By Evy Lewis Published June 5, 2025 at 4:00 AM CDT Listen • 3:48 ...

More information: P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials, The BMJ (2025). DOI: 10.1136/bmj-2024-082561 ...

Investing.com -- Shares of Bayer AG (ETR: BAYGN) were up over 5% on Thursday after Goldman Sachs upgraded the German pharmaceutical and life sciences company to a "buy" rating from "neutral." ...